相关实验视频

Updated: May 3, 2026

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

伊米基莫德诱导的大肠炎:一种新的ROS/ERK驱动的肠炎和屏障功能障碍的模型

Kuang-Ting Liu¹, Shu-Hao Chang², Kuan-Chen Wu³

¹Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan; Department of Pathology & Laboratory Medicine, Taoyuan Armed Forces General Hospital, Taoyuan, Taiwan.

Chemico-biological interactions

|January 8, 2026

概括

伊米基莫德 (IMQ) 通过通过活性氧物种 (ROS) 破坏肠道屏障,引发肠道炎症. 抗氧化剂可以逆转这些影响,这表明了炎症性肠病 (IBD) 的新治疗方法.

科学领域:

胃肠道学和免疫学
分子生物学和病理学分子生物学和病理学

背景情况:

牛皮和炎症性肠病 (IBD) 是慢性免疫媒介疾病,共享共同的致病途径.
已知伊米基莫德 (IMQ) 诱导皮肤炎症并加剧肠道炎症,与反应性氧物种 (ROS) 有关.
ROS在IMQ诱导的肠炎中的确切作用及其治疗潜力尚未完全阐明.

研究的目的:

为了研究ROS在IMQ诱导肠道结肠炎的发病过程中的作用.
使用IMQ.建立一种新的小鼠结肠炎模型.
评估针对ROS在IBD中的治疗潜力.

主要方法:

小鼠被暴露在伊米基莫德 (IMQ) 中以诱导大肠炎.
评估肠道屏障功能,包括粘液层的完整性,粘素2的产生,以及紧密结节的破坏.
对ROS/细胞外信号调节激酶 (ERK) 途径的研究.
对抗氧化剂预治疗对大肠炎症状和屏障功能的影响的评估.

主要成果:

通过耗尽粘液层和减少粘素2,增加肠道透性,IMQ直接诱导大肠炎类炎症.
通过ROS/ERK通路,IMQ破坏了肠道紧结,并削弱了通过ROS/ERK通路的屏障功能.
抗氧化剂预治疗显著缓解了结肠炎症状,并恢复了肠道屏障的完整性.

结论:

IMQ通过ROS依赖的机制诱导肠道炎症和屏障功能障碍,建立了相关的IBD模型.
在IMQ诱导的肠道病理中,ROS/ERK通路至关重要.
这种IMQ诱导的结肠炎模型作为一个有价值的平台来评估IBD的氧化还原调节疗法.

关键词:

大肠炎是什么意思艾米基基莫德 (Imiquimod) 是一种药物.肠道粘膜屏障肠道粘膜屏障肠道粘膜屏障鼠模型的模型.有反应性氧物种的反应性氧物种.紧密的结口是紧密的结口.

更多相关视频

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Published on: September 18, 2016

Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids

Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids

Published on: June 2, 2023

相关概念视频

Inflammatory Bowel Disease I: Ulcerative Colitis

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

Inflammatory Bowel Disease II: Ulcerative Colitis

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...

Inflammatory Bowel Disease III: Crohn's Disease

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...